Patient Guide: A Study of Brentuximab Vedotin in Combination With Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Prednisone (CHP) in Chinese Participants With CD30-Positive (CD30+) Peripheral T-Cell Lymphomas (PTCL)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 16 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05673785
Status: ACTIVE_NOT_RECRUITING
Condition: Lymphoma, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral
Phase: PHASE2

Find a Study Location Near You

This study is available at 16 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Beijing,
  • Beijing,
  • Changchun,
  • • And 13 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily